Literature DB >> 30800558

SGLT2 inhibitors and protection against pancreatic beta cell failure.

Shun-Ichiro Asahara1, Wataru Ogawa1.   

Abstract

Entities:  

Year:  2018        PMID： 30800558      PMCID： PMC6357236          DOI： 10.1007/s13340-018-0374-y

Source DB:  PubMed          Journal:  Diabetol Int        ISSN： 2190-1678


× No keyword cloud information.
  5 in total

1.  MiR-34a-5p and miR-452-5p: The Novel Regulators of Pancreatic Endocrine Dysfunction in Diabetic Zucker Rats?

Authors:  Tong Su; Jiejun Hou; Tonghua Liu; Pei Dai; LingLing Qin; Lei Ding; Yan Hu; Xiangyu Guo
Journal:  Int J Med Sci       Date:  2021-07-11       Impact factor: 3.642

Review 2.  Novel Approaches to Restore Pancreatic Beta-Cell Mass and Function.

Authors:  Alena Welters; Eckhard Lammert
Journal:  Handb Exp Pharmacol       Date:  2022

3.  Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice.

Authors:  Toru Kusakabe; Shigefumi Yokota; Mika Shimizu; Takayuki Inoue; Masashi Tanaka; Ryuji Ohue-Kitano; Kazuya Muranaka; Hajime Yamakage; Hiromichi Wada; Koji Hasegawa; Noriko Satoh-Asahara
Journal:  BMJ Open Diabetes Res Care       Date:  2020-09

Review 4.  Endoplasmic Reticulum-Mitochondria Crosstalk and Beta-Cell Destruction in Type 1 Diabetes.

Authors:  Saurabh Vig; Joost M Lambooij; Arnaud Zaldumbide; Bruno Guigas
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

5.  The Effect of SGLT2 Inhibition on Diabetic Kidney Disease in a Model of Diabetic Retinopathy.

Authors:  Jennifer Rose Matthews; Markus P Schlaich; Elizabeth Piroska Rakoczy; Vance Bruce Matthews; Lakshini Yasaswi Herat
Journal:  Biomedicines       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.